Covid cases in India: Mumbai, Pune, Chennai log fresh cases
Health authorities are closely observing a rise in Covid-19 cases across several Indian states, as infections resurge in parts of Asia, including Hong Kong and Singapore. While nationwide numbers remain low compared to earlier waves, cities such as Mumbai, Chennai, and Ahmedabad have witnessed a modest but noticeable increase in infections.
Mumbai has reported 95 new Covid-19 cases so far in May, a significant rise given that Maharashtra has recorded only 106 cases since January, according to the state health department. At least 16 patients are currently hospitalised, with many transferred from KEM Hospital to Seven Hills Hospital to prevent further transmission, Times of India reported.
All patients presenting with influenza-like illness (ILI) or severe acute respiratory infection (SARI) are now being tested for Covid-19.
In Pune, municipal authorities have kept 50 beds reserved at Naidu Hospital as a precautionary measure, despite the absence of active Covid-19 patients in public hospitals.
'We had only one patient in May — an 87-year-old from Manjari — who has since fully recovered,' Dr Nina Borade, health chief at Pune Municipal Corporation was quoted as saying by TOI.
She noted that testing is currently not being carried out in civic hospitals and that the city is awaiting updated guidelines from the Centre.
In Tamil Nadu, 12 new cases have emerged in Puducherry. In Chennai, a shift is being observed as fevers initially attributed to influenza are increasingly being linked to Covid-19.
Some hospitals have delayed crucial procedures, including organ transplants and cardiac surgeries, due to heightened infection risk.
'We are seeing a rising share of Covid-19 among viral cases,' Dr Subramaniam Swaminathan, an infectious diseases expert at Gleneagles Healthcity was quoted as saying by TOI. 'Two weeks ago, 60% of our positive samples were influenza A or B. Now, it's Covid-19.'
Public Health Director Dr T S Selvavinayagam urged caution in crowded areas but said there was 'no need for panic'. He added: 'Covid-19 never truly disappeared — it has been circulating at low levels with seasonal peaks.'
Karnataka has 16 active cases, state health minister Dinesh Gundu Rao confirmed.
Meanwhile, Gujarat reported seven new infections in Ahmedabad in a single day — an unusual increase for a city that has averaged only one case per month over the past year. All patients are in home isolation, and their samples have been sent for genomic sequencing.
Though the World Health Organization declared the pandemic over in May 2023, the virus continues to circulate globally.
In India, most new infections have been mild, with no reported deaths or ICU admissions linked to the current rise.
Health professionals are urging vulnerable groups — including the elderly, pregnant women, and individuals with underlying conditions — to reinstate basic precautions such as mask-wearing in enclosed spaces and frequent hand hygiene.
Doctors have also recommended influenza vaccination to minimise the risk and impact of potential co-infections.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
&w=3840&q=100)
First Post
42 minutes ago
- First Post
Beyond irregular periods: How AMH+ and other new tests are changing PCOS diagnosis for Indian women
Polycystic Ovary Syndrome is rising among Indian women, especially in urban areas. This article explores its symptoms, diagnostic challenges, and how new tools like the AMH+ test offer accurate, non-invasive early detection—empowering women to manage their reproductive health more effectively and proactively. read more Polycystic Ovary Syndrome (PCOS) has emerged as one of the most prevalent hormonal disorders affecting women of reproductive age. Recent studies, including one published in the Journal of the American Medical Association (JAMA), estimate that PCOS affects between 7.2 per cent to 19.6 per cent of Indian women with higher prevalence seen in urban populations. The condition, characterised by hormonal imbalance and metabolic issues, can lead to a range of symptoms, from irregular periods and weight gain to acne, excessive hair growth and infertility. STORY CONTINUES BELOW THIS AD Firstpost talked to Dr. Rishma Pai, an honorary consultant Gynaecologist at the Lilavati, HN Reliance Hospital and Hinduja Hospitals (Mumbai) to understand the growing burden of PCOS in India, the diagnostic challenges women face and how new tools like the AMH+ test are transforming early detection and management. The Rising Tide of PCOS in India Dr Rishma: Urbanisation, sedentary lifestyles, poor dietary habits, and increasing stress levels have all contributed to the rising prevalence of PCOS in India. Coupled with low awareness and stigma surrounding reproductive health, many women either ignore the signs or seek medical attention too late. PCOS is not just a reproductive issue if left unmanaged, it can increase the risk of type 2 diabetes, cardiovascular disease, and endometrial cancer. The Diagnostic Dilemma Dr Rishma: PCOS is often diagnosed using the Rotterdam criteria, which require at least two of the following three features: irregular or absent periods, signs of high androgen levels (clinically or through lab reports), and polycystic ovaries on ultrasound. However, this process can be prolonged and inconsistent. Many women go undiagnosed for years, which delays treatment and worsens their overall health outcomes. Common Challenges Faced by Women Delayed or missed diagnosis due to lack of awareness Discomfort with transvaginal ultrasounds, especially for unmarried women Mismanagement of symptoms, often treated in isolation (e.g., only acne or only irregular periods) Mental health toll due to chronic stress, infertility struggles, and body image issues Diagnostic Tests Available for PCOS in India While we talk about it, there are a range of diagnostic tests available in India. These include: Ultrasound Scan (Pelvic or Transvaginal Ultrasound) Used to detect the presence of multiple small follicles on the ovaries, which gives the condition its name. Often done on Day 2 or 3 of the menstrual cycle. May not be preferred by or suitable for all women, especially those who are unmarried. Hormone Blood Tests These measure levels of testosterone, LH (Luteinizing Hormone), FSH (Follicle-Stimulating Hormone), and prolactin. Elevated androgens or a high LH:FSH ratio can indicate hormonal imbalance typical of PCOS. Glucose and Insulin Resistance Tests Includes fasting glucose, insulin levels, and HbA1c to check for insulin resistance or prediabetes. Insulin resistance is a common but under-recognized reason behind PCOS. AMH+ Test (Anti-Müllerian Hormone) A simple blood test that measures AMH levels to evaluate ovarian reserve and function. High AMH levels are associated with PCOS as they reflect the increased load of antral follicles. Therefore, AMH+ is an important indicator to identify PCOS. While there are other AMH tests available in India from different manufacturers, the AMH+ test developed by Roche Diagnostics is the first DCGI-approved diagnostic tool for PCOM in aiding the diagnosis of PCOS in India. It is also CE-marked in Europe, reinforcing its global and regulatory credibility. STORY CONTINUES BELOW THIS AD Unlike traditional diagnostic methods like transvaginal ultrasound, which must be timed with the menstrual cycle and can be invasive, AMH+ can be conducted on any day of the cycle, offering a more convenient, accessible, and non-invasive option. It is the most accurate and reliable test available to diagnose PCOS. Thyroid Function Tests and Lipid Profile Thyroid dysfunction and lipid imbalances are commonly associated with PCOS. These tests are crucial in evaluating broader metabolic impacts and ruling out other conditions that mimic PCOS symptoms. Timely and accurate diagnosis is the first step in managing PCOS effectively. With newer diagnostic tools like the AMH+ test, combined with clinical insights and lifestyle guidance, women can take proactive control over their reproductive health.
Time of India
an hour ago
- Time of India
US to stop financial support of global vaccine alliance Gavi, health secretary says
Live Events (You can now subscribe to our (You can now subscribe to our Economic Times WhatsApp channel Health Secretary Robert F. Kennedy Jr. said on Wednesday that the U.S. government will no longer contribute to Gavi, accusing the group that helps buy vaccines for the world's poorest children of ignoring safety, without providing a video statement seen by Reuters and shown at a Gavi fundraising event in Brussels, Kennedy - a long-time vaccine skeptic - also accused the organization of making questionable recommendations around COVID-19 vaccines, and raised concerns about the DTPw (diphtheria-tetanus-whole cell pertussis) said in a statement that safety was key, and that it acts in line with World Health Organization recommendations. It has full confidence in the DTPw vaccine, which has contributed to halving child mortality in the countries it supports since 2000, the statement continued."I call on Gavi today to re-earn the public trust, and to justify the $8 billion that America has provided in funding since 2001," Kennedy said in the video, saying Gavi should consider all available science."Until that happens, the United States won't contribute more," he details of the video were first reported by said it "fully concurs with the Secretary for Health and Human Services on the need to consider all available science, and remains committed to continuing an evidence-based and scientific approach to its work and investment decisions, as it always has done."Gavi leaders, donors and countries it works with are in Brussels for the organization's pledging summit, where the alliance aims to raise $9 billion for its work from said in the video that he admired much of Gavi's work, particularly its efforts to make medicines affordable worldwide."Unfortunately, in its zeal to promote universal vaccination, it has neglected the key issue of vaccine safety," he added."Gavi's utmost concern is the health and safety of children," the group's statement Trump administration has previously indicated that it planned to cut its funding for Gavi, representing around $300 million annually, as part of a wider pullback from international Donald Trump's nominee for director of the Centers for Disease Control and Prevention , Susan Monarez, was asked about the Gavi decision at a Senate hearing on Wednesday."I believe the global health security preparedness is a critical and vital activity for the United States," she said."I think that we need to continue to support promotion of utilization of vaccines," she continued, adding that she was not involved in that decision-making and would look into it if donors, including Germany, Norway, and the Gates Foundation, have already pledged money in recent days for Gavi's future work.
Time of India
an hour ago
- Time of India
The Hidden Heart Risk: Early Intervention Key for Diabetics Over 40
India is at the centre of a growing health crisis where diabetes and heart disease are deeply intertwined. The number of people living with diabetes in the country is rising sharply—not only among the elderly but alarmingly among younger age groups, including those in their 30s and 40s. As this trend accelerates, a concerning fact becomes clear: people with diabetes, particularly those in their 40s, face a significantly higher risk of developing cardiovascular disease (CVD). Dr. Pallab Biswas, MD (Internal Medicine), DM CardiologyQuote: Metabolic syndrome, seen frequently in urban Indian adults post-40, significantly increases the risk of heart attacks. Waist size, fasting glucose, HDL, and triglycerides are crucial markers. Routine health checks can help manage these before complications set in. Diabetes and the Hidden Heart Risk Diabetes is not just a condition of elevated blood sugar—it is a serious metabolic disorder that affects nearly every system in the body. Among its most dangerous effects is its role as a major risk factor for heart disease. High blood sugar levels damage blood vessels over time, contributing to plaque buildup, inflammation, and reduced blood flow—making heart attacks, strokes, and other cardiovascular events much more likely. In fact, cardiovascular disease is the leading cause of death in people with diabetes. The risk starts building silently, often years before any symptoms are noticed. This means that many people who are newly diagnosed with diabetes may already have underlying heart complications or be at a significantly elevated risk of developing them. Dr. Anil Choudhary, MD (Internal Medicine), DM CardiologyQuote: Turning 40 is not a health decline-it's a wake-up call. Your heart has been working hard for decades. Support it with healthy habits, manage stress, and never ignore signs like fatigue or chest discomfort. Prevention begins with awareness. The 40s: A Decade That Demands Attention The 40s are a crucial phase for health management. It is often during this decade that the long-term effects of lifestyle choices—such as poor diet, lack of exercise, high stress, and sedentary habits—begin to manifest more clearly. When combined with diabetes, these factors accelerate the risk of cardiovascular complications. That's why early and aggressive intervention during this phase is not just recommended, but essential. Without proper management, the risk of heart disease increases significantly in the years that follow. Dr. Vinod Vadthya, Consultant Interventional Cardiologist, DrNB (Cardiologist)Quote: Heart disease doesn't begin at 60-it builds silently from 40. Prioritize your health now with regular screenings, a balanced diet, and daily movement. Small actions today prevent major consequences tomorrow. Remember, the earlier you act, the longer your heart will serve you well. Rising Prevalence Among Younger Adults India is witnessing a surge in diabetes diagnoses among young adults. Sedentary lifestyles, unhealthy eating habits, increasing obesity rates, and genetic predisposition are contributing to early-onset diabetes. This younger population, already vulnerable due to early exposure, may accumulate a longer duration of high cardiovascular risk over time. As a result, there is an urgent need for early screening and preventive strategies—not just for blood sugar management but also for heart health protection. Dr Muhammad Musthafa M, Consultant Interventional Cardiologist, MD(Medicine) DrNB(Cardio)Quote: Indians develop heart disease nearly a decade earlier than Western populations. After 40, monitor cholesterol, blood sugar, and blood pressure regularly. A sedentary lifestyle, high-carb diet, and stress only accelerate cardiovascular risk. Prevention starts with awareness and regular health checkups Statins: A Proven Shield Against Heart Disease To address this dual threat, early intervention with therapies that go beyond blood sugar control is vital. One of the most widely recommended treatments is statin therapy. According to the American Diabetes Association, all individuals aged 40 and above with diabetes should be prescribed at least moderate-intensity statin therapy, regardless of their baseline cholesterol levels. This recommendation is based on extensive research that shows statins help reduce the risk of major cardiovascular events by lowering LDL ('bad') cholesterol and stabilizing plaque in arteries. Starting statins early, especially in people in their 40s with diabetes, offers a layer of protection that lifestyle changes alone may not achieve quickly enough. When used in combination with better diet, regular physical activity, and blood pressure management, statins provide a strong defense against heart disease. Dr. Divyen Kothia, Consultant Interventional Cardiologist, MD Medicine, DM, Interventional CardiologyQuote: Stress, poor sleep, and sedentary habits take a toll after 40. Heart disease doesn't appear overnight- it builds over time. Address risk factors early. Your heart has been loyal to you, now it's your turn to be loyal to it. A Call to Act Now Preventing heart disease in people with diabetes isn't just about managing blood sugar. It's about recognizing the broader cardiovascular risks and addressing them head-on—especially during the 40s when the risks start to climb steeply. For Indian adults living with diabetes, especially those recently diagnosed or in their early 40s, now is the time to act. Early intervention with statin therapy, along with lifestyle changes, regular monitoring, and consistent follow-up, can significantly lower the risk of heart-related complications. The message is clear: don't wait for symptoms. Heart disease often strikes without warning. Acting early can make the difference between a future filled with health and one burdened by preventable illness. Disclaimer - The above content is non-editorial, and ET Healthworld hereby disclaims any and all warranties, expressed or implied, relating to it, and does not guarantee, vouch for or necessarily endorse any of the content.
